Managing HRT-Related Bleeding

Initial Assessment

• The American College of Obstetricians and Gynecologists recommends ruling out underlying gynecological problems that could cause prolonged bleeding, including pregnancy, sexually transmitted infections, and pathologic uterine conditions, in women experiencing bleeding during Hormone Replacement Therapy (HRT) 1
• Documenting specific bleeding characteristics, including frequency, duration, and amount of flow, is essential for assessing HRT-related bleeding 3
• Assessing pattern changes over time and presence of pain is crucial for determining the appropriate treatment for HRT-related bleeding 3

Treatment Algorithm for HRT Bleeding

First-Line Treatment

• The Centers for Disease Control and Prevention recommends NSAIDs for short-term treatment (5-7 days) during days of bleeding for women experiencing HRT-related bleeding 1
• Mefenamic acid 500 mg three times daily for 5 days can be used as a first-line treatment for HRT-related bleeding 2
• Celecoxib 200 mg daily for 5 days is another option for first-line treatment of HRT-related bleeding 2

Second-Line Treatment (if bleeding persists)

• The American College of Obstetricians and Gynecologists recommends low-dose combined oral contraceptives for short-term treatment (10-20 days) if medically eligible for women with persistent HRT-related bleeding 1
• A hormone-free interval of 3-4 days can help reduce bleeding in women taking continuous combined HRT regimens 4

For Continuous Combined HRT Regimens

• A short hormone-free interval (3-4 days) can help reduce bleeding, with studies showing an initial increase in flow followed by an abrupt decrease and eventual cessation of flow 11-12 days later 4
• Oral doxycycline (100 mg twice daily for 5 days) has not shown improvement in bleeding compared to placebo for women taking continuous combined HRT regimens 4

When to Consider Alternative Approaches

• The Centers for Disease Control and Prevention recommends counseling women on alternative contraceptive methods if bleeding persists despite treatment and the woman finds it unacceptable 1

Follow-up Recommendations

• Discussing the expected timeline for improvement is essential for managing HRT-related bleeding 3
• Explaining potential side effects of treatments is crucial for women experiencing HRT-related bleeding 3
• Scheduling appropriate follow-up to monitor response to treatment is necessary for determining the effectiveness of HRT-related bleeding treatment 3
• Instructing when to seek urgent medical attention is vital for women experiencing HRT-related bleeding 3